Related references
Note: Only part of the references are listed.Optimization of trans-Resveratrol bioavailability for human therapy
Marie Josephe Amiot et al.
BIOCHIMIE (2013)
Repeated and long-term treatment with physiological concentrations of resveratrol promotes NO production in vascular endothelial cells
Satoru Takahashi et al.
BRITISH JOURNAL OF NUTRITION (2012)
Molecular Pathways: Digoxin Use and Estrogen-Sensitive Cancers-Risks and Possible Therapeutic Implications
Robert J. Biggar
CLINICAL CANCER RESEARCH (2012)
Calpain-mediated Processing of p53-associated Parkin-like Cytoplasmic Protein (PARC) Affects Chemosensitivity of Human Ovarian Cancer Cells by Promoting p53 Subcellular Trafficking
Michael G. Woo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Piceatannol, Natural Polyphenolic Stilbene, Inhibits Adipogenesis via Modulation of Mitotic Clonal Expansion and Insulin Receptor-dependent Insulin Signaling in Early Phase of Differentiation
Jung Yeon Kwon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The oncogenic phosphatase PPM1D confers cisplatin resistance in ovarian carcinoma cells by attenuating checkpoint kinase 1 and p53 activation
A. Y. Ali et al.
ONCOGENE (2012)
被撤回的出版物: Selective killing of cancer cells by a small molecule targeting the stress response to ROS (Retracted article. See vol. 561, pg. 420, 2018)
Lakshmi Raj et al.
NATURE (2011)
Phosphoinositide 3-kinase is a novel target of piceatannol for inhibiting PDGF-BB-induced proliferation and migration in human aortic smooth muscle cells
Keun Hwa Choi et al.
CARDIOVASCULAR RESEARCH (2010)
Smac mimetics increase cancer cell response to chemotherapeutics in a TNF-α-dependent manner
B. L. Probst et al.
CELL DEATH AND DIFFERENTIATION (2010)
Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein
M. R. Abedini et al.
ONCOGENE (2010)
Loss of Parkin or PINK1 Function Increases Drp1-dependent Mitochondrial Fragmentation
A. Kathrin Lutz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Cisplatin induces p53-dependent FLICE-like inhibitory protein ubiquitination in ovarian cancer cells
Mohammad R. Abedini et al.
CANCER RESEARCH (2008)
Bax- or Bak-induced mitochondrial fission can be uncoupled from cytochrome c release
Clare Sheridan et al.
MOLECULAR CELL (2008)
Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria
G. M. Cereghetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Melatonin supplementation modifies experimental chronic colitis in mice
M. Golab et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2008)
Cisplatin: a review of toxicities and therapeutic applications
K. Barabas et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2008)
Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function
Michael Fraser et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Functions and dysfunctions of mitochondrial dynamics
Scott A. Detmer et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Regulation of mitochondrial fusion and division
Kara L. Cerveny et al.
TRENDS IN CELL BIOLOGY (2007)
Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death
J. Thomas Cribbs et al.
EMBO REPORTS (2007)
Drp1 mediates caspase-independent type III cell death in normal and leukemic cells
Marlene Bras et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
The mitochondrial fission protein hFis1 requires the endoplasmic reticulum gateway to induce apoptosis
Emilie Alirol et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Akt-mediated cisplatin resistance in ovarian cancer: Modulation of p53 action on caspase-dependent mitocliondrial death pathway
XK Yang et al.
CANCER RESEARCH (2006)
The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor α in human breast cancer cells
M Maggiolini et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2005)
Regulation of mitochondrial fission and apoptosis by the mitochondrial outer membrane protein hFis1
TZ Yu et al.
JOURNAL OF CELL SCIENCE (2005)
Mitochondrial fission in apoptosis
RJ Youle et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Possible role of FLICE-like inhibitory protein (FLIP) in chemoresistant ovarian cancer cells in vitro
MR Abedini et al.
ONCOGENE (2004)
Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches
PJ Hesketh et al.
SUPPORTIVE CARE IN CANCER (2004)
Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer
TJ Shaw et al.
MOLECULAR THERAPY (2004)
Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis
YJ Lee et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Cisplatin: mode of cytotoxic action and molecular basis of resistance
ZH Siddik
ONCOGENE (2003)
Cancer chemoprevention with dietary phytochemicals
YJ Surh
NATURE REVIEWS CANCER (2003)
Integral role of Noxa in p53-mediated apoptotic response
T Shibue et al.
GENES & DEVELOPMENT (2003)
Mechanism of XIAP-mediated inhibition of caspase-9
EN Shiozaki et al.
MOLECULAR CELL (2003)
Part II: Chemotherapy for epithelial ovarian cancer - treatment of recurrent disease
M Harries et al.
LANCET ONCOLOGY (2002)
Systematic review of first-line chemotherapy for newly diagnosed postoperative patients with stage II, III, or IV epithelial ovarian cancer
A Covens et al.
GYNECOLOGIC ONCOLOGY (2002)
The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYPIBI
GA Potter et al.
BRITISH JOURNAL OF CANCER (2002)
X-linked inhibitor of apoptosis protein (XIAP) inhibits caspase-3 and-7 in distinct modes
Y Suzuki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
X-linked inhibitor of apoptosis protein activates the phosphatidylinositol 3-kinase/Akt pathway in rat granulosa cells during follicular development
E Asselin et al.
ENDOCRINOLOGY (2001)
Structural and biochemical basis of apoptotic activation by Smac/DIABLO
JJ Chai et al.
NATURE (2000)
Nora, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis
E Oda et al.
SCIENCE (2000)
Share Paper
